Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Japan Advances Rare Earths Ambitions with World’s First Seabed Trial February 4, 2026 Can You Invest in Neuralink? February 4, 2026 Westport Announces $6.5 Million Milestone Payment From Light-Duty Divestiture February 4, 2026